Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 03, 2015 8:09 AM ET

Healthcare Equipment and Supplies

Company Overview of KineMed, Inc.

Company Overview

KineMed, Inc. develops and commercializes proprietary biomarker platform technology. The company focuses on applying its proprietary biomarker platform technology to drug development, prescription, and non-prescription medical diagnostics and the pairing of drugs with diagnostic biomarker tests. It plans to commercialize biomarkers in the areas of muscle biology, fibrotic diseases, neurodegenerative diseases, cardiometabolic diseases, skin care, and cancer. The company was founded in 2001 and is based in Emeryville, California.

5980 Horton Street

Suite 470

Emeryville, CA 94608

United States

Founded in 2001

49 Employees

Phone:

510-655-6525

Fax:

510-655-6506

Key Executives for KineMed, Inc.

Co-Founder, Chairman and Chief Executive Officer
Age: 71
Co-Founder, Chairman of the Scientific Advisory Board, President, Chief Scientific Officer and Director
Age: 63
Chief Operating Officer
Age: 82
Chief Business Officer and Executive Vice President
Executive Vice President of Research & Development
Age: 44
Compensation as of Fiscal Year 2015.

KineMed, Inc. Key Developments

KineMed, Inc. and Pronutria Biosciences Enters Research and Development Collaboration

KineMed, Inc. and Pronutria Biosciences, Inc. announced a collaboration under which KineMed will apply its dynamic proteomics platform to assist Pronutria in evaluating novel biologics designed to restore cellular homeostasis in amino acid biology. Pronutria Biosciences is a clinical-stage biotechnology company pioneering a new class of therapeutics to mediate amino acid biology for patients facing serious diseases who currently have few or no treatment options. Pronutria is rapidly advancing research and development programs in several nutritional and therapeutic areas including myopenia (or muscle wasting), metabolic, neurological and liver disorders. Pronutria will utilize the KineMed platform to assess the physiologic effects of its compounds in preclinical and clinical studies. KineMed's ability to rapidly evaluate changes in protein balance is uniquely valuable in assessing the physiologic impact of proteins in different conditions, stated Robert Connelly, President and Chief Executive Officer of Pronutria. KineMed's dynamic proteomics platform is designed to rapidly detect target engagement, track disease progression and provide data that are predictive of later-stage clinical trial outcomes.

KineMed, Inc. Presents at JMP Securities Life Sciences Conference, Jun-24-2015 03:30 PM

KineMed, Inc. Presents at JMP Securities Life Sciences Conference, Jun-24-2015 03:30 PM. Venue: The St. Regis New York, 2 East 55th Street, New York, NY 10022, United States.

KineMed, Inc. Presents at BioEquity Europe 2015, May-19-2015 04:40 PM

KineMed, Inc. Presents at BioEquity Europe 2015, May-19-2015 04:40 PM. Venue: InterContinental Vienna, Vienna, Austria.

Similar Private Companies By Industry

Company Name Region
Advanced Polymers, Inc. United States
Verimetrix, LLC United States
Pansend, LLC United States
Gard Medical United States
Interventional Imaging, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
June 11, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KineMed, Inc., please visit www.kinemed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.